From case reports to citations, niche publications provide relevant clinical knowledge.
By Masaru Tanaka and László Vécsei

László VécseI

Masaru Tanaka
Case reports, once relegated to the sidelines of medical publishing, are re-emerging as powerful vehicles of discovery and innovation. Their renewed relevance lies in the intersection of open access models, digital discoverability, and artificial intelligence (AI)-driven indexing, which collectively amplify their visibility and influence.
In neurology, a single patient’s presentation can unveil the earliest markers of novel syndromes, atypical drug responses, or rare comorbidities. By filling gaps that randomized trials often overlook, case reports serve as fertile niches of clinical knowledge, transforming isolated observations into signals that shape diagnostics, therapeutics, and even public health preparedness.
Many landmark breakthroughs in neurology first appeared in the form of case reports, acting as sparks for broader scientific exploration. Early descriptions of autoimmune encephalitis, novel epilepsy syndromes, and the neurological sequelae of COVID-19 exemplify how single observations can shift entire paradigms. These narratives not only refine diagnostic reasoning, but also provide fertile ground for therapeutic innovation, as seen with precision approaches guided by exome sequencing in rare neurodevelopmental disorders. By translating isolated clinical puzzles into structured knowledge, case reports create a scaffold for systematic studies, ultimately informing guidelines and accelerating the path from bedside insight to bedside intervention.
The digital era has given case reports unprecedented visibility, transforming them from isolated anecdotes into globally accessible clinical resources. Open-access publishing ensures that rare and novel cases, such as paraneoplastic syndromes linked to unusual antibodies, can be consulted by physicians anywhere without subscription barriers. AI and natural language processing further accelerate this accessibility, enabling even the most specific observations to surface instantly in searches and databases.
Beyond access, curated metadata and electronic case reporting systems enhance interoperability, creating structured knowledge that informs both bedside care and population-level surveillance. This democratization of information ensures no clinical insight is ever too small to spark discovery or therapeutic innovation.
For practicing neurologists, case reports serve as direct bridges from literature to bedside, offering insights that randomized trials often fail to capture. They illuminate atypical trajectories of common diseases, highlight red flags in complex diagnostic puzzles, and showcase therapeutic strategies tested in real-world contexts. A single report of an unusual drug reaction or a multidisciplinary approach to refractory neuropsychiatric symptoms can alter daily practice far more rapidly than large-scale studies.
By mirroring the heterogeneity and unpredictability of clinical reality, case reports provide neurologists with immediate, pragmatic guidance. They also nurture hypothesis generation, fostering innovation where evidence is scarce and ensuring that patient-centered problem solving remains central to neurological care.
Bibliometric analyses reveal that case reports are no longer peripheral but increasingly cited across reviews, guidelines, and even meta-analyses, reflecting a cultural and technological shift in their perceived value. In neurology, citation growth is particularly striking in rare disease, neuroimmunology, and neuroinfectious disease, where single observations often carry outsized weight.
Open-access platforms and powerful indexing tools ensure that a report on, for example, an unusual antibody-mediated encephalitis can rapidly inform both clinical reasoning and research agendas. Case-based reviews further amplify this trend, transforming individual narratives into collective evidence streams that directly shape diagnostic frameworks and therapeutic strategies in complex neurological care.
A well-crafted case report can transform a single patient’s story into a driver of global clinical progress. In neurology, documenting rare syndromes or unexpected therapeutic responses provides immediate lessons while shaping broader frameworks for diagnosis and care. These small stories catalyze recognition, spark innovation, and enable knowledge to cross borders, ultimately improving outcomes for patients everywhere. •
Disclosure: This article has been previously published in the Danube Neurology Newsletter and is republished here with permission.
Masaru Tanaka is a senior researcher at Danube Neuroscience Research Laboratory, HUN-REN-SZTE Neuroscience Research Group, Hungarian Research Network, and the University of Szeged, in Szeged, Hungary. László Vécsei is a professor of neurology and head of the Neuroscience Research Group in the Department of Neurology at Albert Szent-Györgyi Medical School, University of Szeged, in Szeged, Hungary.
References:
- Polunosika E, Pastare D, Karelis G, Vasylovska V. (2025). Development of anti-NMDA receptor encephalitis in a patient with multiple sclerosis. BMJ case reports, 18(5), e263945. https://doi.org/10.1136/bcr-2024-263945
- Nan D, Zhang Y, Han J, Jin T. (2021). Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis: a case report and review of the literature. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 42(3), 847–855. https://doi.org/10.1007/s10072-020-04942-0
- Vasilevska V, Guest PC, Bernstein HG, Schroeter ML, Geis C, Steiner J. (2021). Molecular mimicry of NMDA receptors may contribute to neuropsychiatric symptoms in severe COVID-19 cases. Journal of neuroinflammation, 18(1), 245. https://doi.org/10.1186/s12974-021-02293-x
- McHattie A W, Coebergh J, Khan F, Morgante F. (2021). Palilalia as a prominent feature of anti-NMDA receptor encephalitis in a woman with COVID-19. Journal of neurology, 268(11), 3995–3997. https://doi.org/10.1007/s00415-021-10542-5
- Schneider J, Ye D, Hill AM, Whitehorn AS. (2020). Continued post-retraction citation of a fraudulent clinical trial report, 11 years after it was retracted for falsifying data. Scientometrics, 125(3), 2877-2913.
- Gupta SM, Naqvi WM, Mutkure KN, Varma A, Thakur S, Umate R. (2022). Bibliometric Analysis on Bibliometric Studies of Case Reports in the Medical Field. Cureus, 14(10), e29905. https://doi.org/10.7759/cureus.29905
- Büyükkıdık S. (2022). A bibliometric analysis: A tutorial for the bibliometrix package in R using IRT literature. Journal of Measurement and Evaluation in Education and Psychology, 13(3), 164-193.
- Tsekhmister Y. (2023). Effectiveness of case-based learning in medical and pharmacy education: A meta-analysis. Electronic Journal of General Medicine, 20(5).
- Sayre JW, Toklu HZ, Ye F, Mazza J, Yale S. (2017). Case Reports, Case Series — From Clinical Practice to Evidence-Based Medicine in Graduate Medical Education. Cureus, 9(8), e1546. https://doi.org/10.7759/cureus.1546
- Battaglia S, Schmidt A, Hassel S, Tanaka M. (2023). Editorial: Case reports in neuroimaging and stimulation. Frontiers in psychiatry, 14, 1264669. https://doi.org/10.3389/fpsyt.2023.1264669
